Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Privia Health Group (PRVA)

Privia Health raises 2026 guidance as Q2 net income rises 237% to $9.0 million

Positive Impact 4 of 5 guidance Written later

Privia Health Group reported second-quarter 2026 revenue of $632.6 million, up 21.4% from a year earlier, and net income attributable to the company of $9.0 million, up from $2.7 million. The company also raised its full-year 2026 guidance for all key financial metrics, including Adjusted EBITDA of $145 million to $155 million, which indicates improved profitability expectations for shareholders.

Key points

  • Q2 2026 revenue was $632.6 million, up 21.4% from $521.2 million in Q2 2025.
  • Q2 2026 net income attributable to Privia was $9.0 million, or $0.07 per share, versus $2.7 million, or $0.02 per share, a year earlier.
  • Q2 2026 Adjusted EBITDA was $37.4 million, up 29.1% from $29.0 million.
  • Updated full-year 2026 guidance includes Adjusted EBITDA of $145 million to $155 million and GAAP revenue of $2.35 billion to $2.45 billion.

The filing

CompanyPrivia Health Group (PRVA)
Form8-K, current report
Filed with the SECAug 6, 2026, 6:23 AM ET
Accession number0001759655-26-000061

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.